Marketing, Media, Wishful Thinking, and Conflicts of Interest: Inflating the Value of New Medical Technology

Marketing, Media, Wishful Thinking

 

Richard A Deyo, MD, MPH

Spring 2009 - Volume 13 Number 2

https://doi.org/10.7812/TPP/08-087

In 1991, Nelene Fox, a 38-year-old mother of three, was diagnosed with breast cancer. She underwent bilateral mastectomies and chemotherapy but nonetheless developed bony metastases. Her physicians said her only chance for survival was high-dose chemotherapy and autologous bone marrow transplantation. Her Health Maintenance Organization (HMO) refused to cover the procedure (around $140,000) on the basis that it was experimental.1

Her husband launched a successful fundraising effort, and Mrs Fox received the procedure, but died eight months later. Her brother, an attorney, sued the HMO for the delay in her therapy, and won $89 million in damages. Similar lawsuits played out across the country with similar awards.

For the media, this was an irresistible David and Goliath story: relatively powerless individual patients were bringing insurance companies and HMOs to their knees. Reporting focused on access to the new technology, not questioning whether it was effective. With the media frenzy and lobbying, lawmakers began requiring insurance coverage for the new procedure. Insurers, facing lawsuits, bad publicity, and new legal requirements, began to routinely cover the new procedure.2

 

Reprint Permissions

The Permanente Journal welcomes requests for reprints and reproduction. Use of any and all published materials is copyrighted and protected.

SUBSCRIPTION

Journal subscriptions for The Permanente Journal are entered for the calendar year. Advance payment in US dollars is required.

CIRCULATION

27,000 print readers per quarter, 15,350 eTOC readers, and in 2018, 2 million page views of TPJ articles in PubMed from a broad international readership.

Indexing

Indexed in MEDLINE, PubMed Central, HINARI, EMBASE, EBSCO Academic Search Complete, rdrb, CrossRef, and SciVerse/Scopus.


Click here to join the eTOC subscription list or text TPJ to 22828. You will receive an Email notice with the Table of Contents of The Permanente Journal.


                                             

 

 

ISSN 1552-5767 Copyright © 2019 thepermanentejournal.org.

All Rights Reserved.